Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Claggett

Showing results (251-260 of 362) with videos related to

Pageof 37
Sort By:
European Journal of Heart Failure|November 22, 2016
Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemiaPatrick Rossignol, Nicolas Girerd, George Bakris, et al.
Journal of Cardiac Failure|August 16, 2025
Rationale, design, and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 left ventricular assist device recipients (ENVAD-HF)Maja Cikes, Ivo Planinc, Jasper J Brugts, et al.
Journal of the American Heart Association|August 23, 2023
Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MIXiaowen Wang, Karola S Jering, Maja Cikes, et al.
Circulation|November 25, 2016
Heart Failure Stages Among Older Adults in the Community: The Atherosclerosis Risk in Communities StudyAmil M Shah, Brian Claggett, Laura R Loehr, et al.
Circulation. Heart Failure|August 12, 2016
Association of Weight and Body Composition on Cardiac Structure and Function in the ARIC Study (Atherosclerosis Risk in Communities)Natalie A Bello, Susan Cheng, Brian Claggett, et al.
Journal of the American Heart Association|May 31, 2017
Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes MellitusEmil Wolsk, Brian Claggett, Marc A Pfeffer, et al.
JACC. Heart Failure|April 16, 2018
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart FailureKevin Damman, Mauro Gori, Brian Claggett, et al.
JAMA Cardiology|November 11, 2023
Natural Language Processing for Adjudication of Heart Failure in a Multicenter Clinical Trial: A Secondary Analysis of a Randomized Clinical TrialJonathan W Cunningham, Pulkit Singh, Christopher Reeder, et al.
Circulation|September 13, 2019
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HFSenthil Selvaraj, Brian Claggett, Andrea Pozzi, et al.
JAMA Cardiology|July 28, 2021
Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis of a Phase 3 Randomized Clinical TrialKieran F Docherty, Pardeep S Jhund, Brian Claggett, et al.
Pageof 37

Showing results (251-260 of 362) with videos related to

Sort By:
Pageof 37
European Journal of Heart Failure|November 22, 2016
Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemiaPatrick Rossignol, Nicolas Girerd, George Bakris, et al.
Journal of Cardiac Failure|August 16, 2025
Rationale, design, and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 left ventricular assist device recipients (ENVAD-HF)Maja Cikes, Ivo Planinc, Jasper J Brugts, et al.
Journal of the American Heart Association|August 23, 2023
Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MIXiaowen Wang, Karola S Jering, Maja Cikes, et al.
Circulation|November 25, 2016
Heart Failure Stages Among Older Adults in the Community: The Atherosclerosis Risk in Communities StudyAmil M Shah, Brian Claggett, Laura R Loehr, et al.
Circulation. Heart Failure|August 12, 2016
Association of Weight and Body Composition on Cardiac Structure and Function in the ARIC Study (Atherosclerosis Risk in Communities)Natalie A Bello, Susan Cheng, Brian Claggett, et al.
Journal of the American Heart Association|May 31, 2017
Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes MellitusEmil Wolsk, Brian Claggett, Marc A Pfeffer, et al.
JACC. Heart Failure|April 16, 2018
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart FailureKevin Damman, Mauro Gori, Brian Claggett, et al.
JAMA Cardiology|November 11, 2023
Natural Language Processing for Adjudication of Heart Failure in a Multicenter Clinical Trial: A Secondary Analysis of a Randomized Clinical TrialJonathan W Cunningham, Pulkit Singh, Christopher Reeder, et al.
Circulation|September 13, 2019
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HFSenthil Selvaraj, Brian Claggett, Andrea Pozzi, et al.
JAMA Cardiology|July 28, 2021
Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis of a Phase 3 Randomized Clinical TrialKieran F Docherty, Pardeep S Jhund, Brian Claggett, et al.
Pageof 37